Medical Technology

@techinasia.com 8 months ago

In 50 Words: Rakuten founder prioritizes US cancer startup amid business losses

@tech.eu 1 year ago

French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment

@tech.eu 2 years ago

Pharmaceutical giant Sanofi invests $180 million in French medical research platform Owkin

@xconomy.com 3 years ago

Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More

@xconomy.com 3 years ago

Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More

@xconomy.com 3 years ago

Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue

@xconomy.com 3 years ago

FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures

@xconomy.com 3 years ago

Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More

@xconomy.com 3 years ago

Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact

@xconomy.com 4 years ago

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

@xconomy.com 4 years ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 4 years ago

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

@xconomy.com 4 years ago

Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic

@xconomy.com 4 years ago

Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow

@xconomy.com 4 years ago

ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More

@techcrunch.com 4 years ago

Google’s SMILY is reverse image search for cancer diagnosis

@xconomy.com 4 years ago

Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer

@xconomy.com 4 years ago

Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?

@xconomy.com 5 years ago

Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More

@xconomy.com 5 years ago

To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango

@xconomy.com 5 years ago

ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front

@xconomy.com 5 years ago

TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push

@xconomy.com 5 years ago

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

@Primary_Immune 5 years ago

Brain Research to Cancer, Stem Cells to Genetics, And All Points Between - The Rising Stars of Science & Medicine, 2018 https://www.statnews.com/wunderkinds/?utm_content=buffer01951&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic #IoT #ITRTG #BigData #DataScience #SciComm #MedEd #genetics #genomics #biotech #STEM #StemCells #technology #RareDisease @statnews https://t.co/xMHr4pMAfG

@xconomy.com 5 years ago

Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo

@xconomy.com 5 years ago

Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More

@xconomy.com 5 years ago

Will New Study Cut Guesswork for Depression Medicine Prescriptions?

@techcrunch.com 6 years ago

Ourotech is taking the guesswork out of cancer treatment

@techcrunch.com 6 years ago

Balderton joins $30M Series D for big data biotech platform play, Sophia Genetics

@venturebeat.com 7 years ago

Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs

@extremetech.com 8 years ago

First cancer-killing virus finally approved by FDA